1. Home
  2. FLS vs MDGL Comparison

FLS vs MDGL Comparison

Compare FLS & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$71.75

Market Cap

9.9B

Sector

Industrials

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$513.38

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLS
MDGL
Founded
1790
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
10.0B
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
FLS
MDGL
Price
$71.75
$513.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
12
Target Price
$85.20
$674.45
AVG Volume (30 Days)
1.5M
294.7K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
1.21%
N/A
EPS Growth
23.36
41.32
EPS
2.64
N/A
Revenue
N/A
$180,133,000.00
Revenue This Year
$6.97
$58.28
Revenue Next Year
$6.11
$46.80
P/E Ratio
$27.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.34
$265.00
52 Week High
$92.41
$615.00

Technical Indicators

Market Signals
Indicator
FLS
MDGL
Relative Strength Index (RSI) 36.11 70.14
Support Level $69.70 $411.87
Resistance Level $73.36 $610.00
Average True Range (ATR) 2.59 24.32
MACD -0.17 10.23
Stochastic Oscillator 11.19 61.84

Price Performance

Historical Comparison
FLS
MDGL

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: